Marshall Wace, LLP Vigil Neuroscience, Inc. Transaction History
Marshall Wace, LLP
- $81.7 Billion
- Q2 2025
A detailed history of Marshall Wace, LLP transactions in Vigil Neuroscience, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 25,900 shares of VIGL stock, worth $208,495. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,900
Previous 476,934
94.57%
Holding current value
$208,495
Previous $848,000
75.83%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding VIGL
# of Institutions
79Shares Held
38MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.84MShares$47 Million10.21% of portfolio
-
Beryl Capital Management LLC Redondo Beach, CA4.61MShares$37.1 Million5.55% of portfolio
-
Northpond Ventures, LLC4.21MShares$33.9 Million51.65% of portfolio
-
Glazer Capital, LLC New York, NY3.01MShares$24.2 Million0.86% of portfolio
-
Oddo Bhf Asset Management Sas Paris, I02.3MShares$18.5 Million0.72% of portfolio
About Vigil Neuroscience, Inc.
- Ticker VIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,268,600
- Market Cap $228M
- Description
- Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...